OrbiMed’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $883K | Hold |
192,700
| – | – | 0.02% | 91 |
|
|
2025
Q1 | $940K | Hold |
192,700
| – | – | 0.02% | 98 |
|
|
2024
Q4 | $1.29M | Hold |
192,700
| – | – | 0.03% | 103 |
|
|
2024
Q3 | $1.49M | Hold |
192,700
| – | – | 0.03% | 107 |
|
|
2024
Q2 | $1.16M | Hold |
192,700
| – | – | 0.02% | 104 |
|
|
2024
Q1 | $1.74M | Hold |
192,700
| – | – | 0.03% | 104 |
|
|
2023
Q4 | $1.83M | Sell |
192,700
-353,600
| -65% | -$3.35M | 0.04% | 97 |
|
|
2023
Q3 | $6.5M | Hold |
546,300
| – | – | 0.14% | 92 |
|
|
2023
Q2 | $13.4M | Hold |
546,300
| – | – | 0.24% | 78 |
|
|
2023
Q1 | $17.1M | Buy |
546,300
+87,868
| +19% | +$2.75M | 0.34% | 72 |
|
|
2022
Q4 | $32.3M | Buy |
458,432
+281,262
| +159% | +$19.8M | 0.62% | 55 |
|
|
2022
Q3 | $15.3K | Buy |
177,170
+35,180
| +25% | +$3.03K | 0.28% | 72 |
|
|
2022
Q2 | $11.7K | Buy |
+141,990
| New | +$11.7K | 0.21% | 86 |
|
|
2021
Q4 | – | Sell |
-115,000
| Closed | -$9.94M | – | 164 |
|
|
2021
Q3 | $9.94M | Buy |
115,000
+59,281
| +106% | +$5.12M | 0.11% | 129 |
|
|
2021
Q2 | $3.03M | Buy |
+55,719
| New | +$3.03M | 0.03% | 153 |
|